Skip to main content

This job has expired

You will need to login before you can apply for a job.

Research Associate, Protein Sciences & Bioconjugation

Employer
Sutro Biopharma, Inc
Location
South San Francisco, CA
Salary
$81,000 - $87,500
Start date
Jul 15, 2024

View more

Job Details

Sutro Biopharma, Inc. is seeking a highly motivated Research Associate with a background in protein expression, bioconjugation and analytics to join the Protein Biochemistry Group. The successful candidate will have a key role in cross-functional teams to advance protein therapeutics, including but not limited to antibody-drug conjugates, PEGylated protein, protein-protein conjugates, and protein-nucleotide conjugates. The critical role will contribute to the optimization and development of cell free technology and bioconjugation techniques. 

Responsibilities
  • Synthesis, characterization, and delivery (in a timely manner) of protein conjugates in support of discovery and development of novel protein therapeutics.
  • Development of bioconjugation and characterization methods to generate novel bioconjugates.
  • Implement and improve the performance of core technologies, and in-vitro biochemical protein synthesis by designing and executing experiments on transcription, translation, protein folding, and analysis
  • Execution of protein analytical methods to characterize protein and bioconjugates using HPLC, LC-MS, UV-vis, gel-electrophoresis, and DLS.
Qualifications:
  • BS in chemical biology, biochemistry, chemistry, molecular biology, or a related field with 0-4 years of experience
  • Experience in the characterization of proteins and protein conjugates using applicable techniques. Comfortable with routine use of HLPC (RP-, HIC-, SEC-, and IEX-). 
  • Hands-on experience in LCMS is a plus, but not required.
  • Experience working with protein through expression, purification, or characterization
  • Demonstrated ability to work independently, learn, and optimize new conjugation techniques and protein analytical methods.
  • Thorough understanding of protein expression, purification, and characterization.
  • Ability to prioritize work assignments, and consistently perform assigned tasks.
 Sound exciting? Apply today and join our team!Sutro Biopharma, Inc. encourages all colleagues to be fully vaccinated for COVID-19 prior to the first date of employment.  As an equal-opportunity employer, we believe in fostering a culture that is inclusive and values diversity in background and opinions. Sutro Biopharma hires extraordinary individuals into every position in the company and is committed to the diversity of our team. Our company progresses without regard to race, ethnicity, gender, sexual orientation, religious belief, age, disability or citizenship status. We are dedicated to creating a safe environment where our employees can grow and succeed together.  We look forward to hearing from candidates who are interested in exploring opportunities with Sutro! Our People & Culture team/hiring managers are unable to respond and do not accept solicitations from third-party agencies.   The anticipated salary range for fully qualified candidates applying for this role at Sutro Biopharma’s California-based locations will be $81,000 - $87,500 (not including bonus, equity, and benefits). The final salary offered will be dependent on several factors that include and are not limited to relevant previous experience, job responsibilities and duration of experience, the type and length of experience within the industry, and education. About Sutro Biopharma     Sutro Biopharma, Inc., is a clinical-stage company relentlessly focused on the discovery and development of precisely designed cancer therapeutics, transforming what science can do for patients. Sutro’s fit-for-purpose technology, including cell-free XpressCF®, provides the opportunity for broader patient benefit and an improved patient experience. Sutro has multiple clinical stage candidates, including luveltamab tazevibulin, or luvelta, a registrational-stage folate receptor alpha (FRα)-targeting ADC in clinical studies. A robust pipeline, coupled with high-value collaborations and industry partnerships, validates our continuous product innovation. Sutro is headquartered in South San Francisco. For more information, follow Sutro on social media @Sutrobio, or visit www.sutrobio.com.  

Company

sutro

 

Sutro Biopharma, Inc., is a clinical-stage company relentlessly focused on the discovery and development of precisely designed cancer therapeutics, transforming what science can do for patients. Sutro’s fit-for-purpose technology, including cell-free XpressCF®, provides the opportunity for broader patient benefit and an improved patient experience. Sutro has multiple clinical stage candidates, including luveltamab tazevibulin, or luvelta, a registrational-stage folate receptor alpha (FolRα)-targeting ADC in clinical studies. A robust pipeline, coupled with high-value collaborations and industry partnerships, validates our continuous product innovation. Sutro is headquartered in South San Francisco. For more information, follow Sutro on social media @Sutrobio, or visit www.sutrobio.com.

Stock Symbol: STRO

Twitter

 

yh

Bill Newell, CEO Interviewed by Brad Loncar, Founder, Biotech TV – “Sutro Biopharma’s CEO on ADCs, non-cell protein synthesis, and more" - view it here 

erf

 

Company info
Website
Phone
650.881.6500
Location
111 Oyster Point Blvd
South San Francisco
California
94080
US

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert